$BNKL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Bionik Laboratories Corp..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Bionik Laboratories Corp.. Get notifications about new insider transactions in Bionik Laboratories Corp. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | BNKL | Bionik Laboratorie ... | AUBERTON-HERVE ANDRE-JACQUES | Chairman | Buy | P | 0.00 | 95,149 | 0 | 95,149 | 0 to 95.1 K |
| Mar 31 2021 | BNKL | Bionik Laboratorie ... | MARTIN JOSEPH R | Director | Buy | P | 0.00 | 26,430 | 0 | 26,430 | 0 to 26.4 K |
| Mar 31 2021 | BNKL | Bionik Laboratorie ... | Matine Charles | Director | Buy | P | 0.00 | 26,430 | 0 | 26,430 | 0 to 26.4 K |
| Mar 31 2021 | BNKL | Bionik Laboratorie ... | MALONE PETER GERALD | Director | Buy | P | 0.00 | 26,430 | 0 | 26,430 | 0 to 26.4 K |
| Nov 27 2019 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Option Exercise | C | 0.00 | 4,997 | 0 | 17,476 | |
| Nov 27 2019 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Buy | C | 0.00 | 4,997 | 0 | 1,282,634 | 1.3 M to 1.3 M (+0.39 %) |
| Oct 03 2019 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Buy | C | 6.80 | 76,225 | 518,330 | 1,277,637 | 1.2 M to 1.3 M (+6.34 %) |
| Oct 03 2019 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Buy | C | 6.80 | 76,225 | 518,330 | 1,277,637 | 1.2 M to 1.3 M (+6.34 %) |
| Aug 28 2019 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Buy | P | 3.76 | 106,358 | 399,906 | 1,201,412 | 1.1 M to 1.2 M (+9.71 %) |
| Aug 08 2019 | BNKL | Bionik Laboratorie ... | AUBERTON-HERVE ANDRE-JACQUES | Director | Option Exercise | A | 3.59 | 115,759 | 415,575 | 115,759 | |
| Jul 30 2019 | BNKL | Bionik Laboratorie ... | Dusseux Eric Michel | Chief Executive Off ... | Option Exercise | A | 3.59 | 115,759 | 415,575 | 115,759 | |
| Jul 30 2019 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Option Exercise | A | 3.59 | 115,759 | 415,575 | 115,759 | |
| Jul 30 2019 | BNKL | Bionik Laboratorie ... | MARTIN JOSEPH R | Director | Option Exercise | A | 3.59 | 19,293 | 69,262 | 19,293 | |
| Jul 30 2019 | BNKL | Bionik Laboratorie ... | Matine Charles | Director | Option Exercise | A | 3.59 | 19,293 | 69,262 | 19,293 | |
| Jul 30 2019 | BNKL | Bionik Laboratorie ... | Thevenon Audrey | Director | Option Exercise | A | 3.59 | 19,293 | 69,262 | 19,293 | |
| Jul 30 2019 | BNKL | Bionik Laboratorie ... | MALONE PETER GERALD | Director | Option Exercise | A | 3.59 | 19,293 | 69,262 | 19,293 | |
| Jun 04 2019 | BNKL | Bionik Laboratorie ... | AUBERTON-HERVE ANDRE-JACQUES | Director | Option Exercise | A | 3.16 | 7,500 | 23,700 | 7,500 | |
| Jun 04 2019 | BNKL | Bionik Laboratorie ... | Thevenon Audrey | Director | Option Exercise | A | 3.16 | 5,000 | 15,800 | 5,000 | |
| Jun 04 2019 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Option Exercise | A | 3.16 | 5,000 | 15,800 | 5,000 | |
| Jun 04 2019 | BNKL | Bionik Laboratorie ... | MARTIN JOSEPH R | Director | Option Exercise | A | 3.16 | 5,000 | 15,800 | 5,000 | |
| Jun 04 2019 | BNKL | Bionik Laboratorie ... | MALONE PETER GERALD | Director | Option Exercise | A | 3.16 | 5,000 | 15,800 | 5,000 | |
| Jun 04 2019 | BNKL | Bionik Laboratorie ... | Dusseux Eric Michel | Chief Executive Off ... | Option Exercise | A | 3.16 | 110,855 | 350,302 | 110,855 | |
| Jun 04 2019 | BNKL | Bionik Laboratorie ... | Matine Charles | Director | Option Exercise | A | 3.16 | 5,000 | 15,800 | 5,000 | |
| Jun 04 2019 | BNKL | Bionik Laboratorie ... | MARKOW LESLIE NADENE | Chief Financial Off ... | Option Exercise | A | 3.16 | 7,400 | 23,384 | 7,400 | |
| Apr 09 2019 | BNKL | Bionik Laboratorie ... | AUBERTON-HERVE ANDRE-JACQUES | Director | Buy | C | 3.89 | 81,492 | 316,800 | 224,475 | 143 K to 224.5 K (+56.99 %) |
| Apr 09 2019 | BNKL | Bionik Laboratorie ... | AUBERTON-HERVE ANDRE-JACQUES | Director | Buy | C | 3.89 | 81,492 | 316,800 | 224,475 | 143 K to 224.5 K (+56.99 %) |
| Apr 05 2019 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Buy | C | 3.89 | 197,234 | 766,747 | 1,095,054 | 897.8 K to 1.1 M (+21.97 %) |
| Jul 26 2018 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Buy | C | 0.05 | 43,468,547 | 2,229,936 | 134,672,664 | 91.2 M to 134.7 M (+47.66 %) |
| Jul 26 2018 | BNKL | Bionik Laboratorie ... | AUBERTON-HERVE ANDRE-JACQUES | Director | Buy | C | 0.05 | 6,688,480 | 343,119 | 21,447,183 | 14.8 M to 21.4 M (+45.32 %) |
| Jun 28 2018 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Buy | C | 0.06 | 15,740,728 | 983,796 | 91,204,117 | 75.5 M to 91.2 M (+20.86 %) |
| Jun 15 2018 | BNKL | Bionik Laboratorie ... | AUBERTON-HERVE ANDRE-JACQUES | Director | Buy | C | 0.06 | 1,039,115 | 64,945 | 14,758,703 | 13.7 M to 14.8 M (+7.57 %) |
| Jun 15 2018 | BNKL | Bionik Laboratorie ... | AUBERTON-HERVE ANDRE-JACQUES | Director | Buy | C | 0.06 | 1,040,152 | 65,010 | 14,758,703 | 13.7 M to 14.8 M (+7.58 %) |
| Apr 24 2018 | BNKL | Bionik Laboratorie ... | Dusseux Eric Michel | Chief Executive Off ... | Option Exercise | A | 0.06 | 6,000,000 | 389,400 | 6,000,000 | |
| Apr 03 2018 | BNKL | Bionik Laboratorie ... | AUBERTON-HERVE ANDRE-JACQUES | Director | Option Exercise | A | 0.06 | 1,600,640 | 100,040 | 1,600,640 | |
| Apr 03 2018 | BNKL | Bionik Laboratorie ... | AUBERTON-HERVE ANDRE-JACQUES | Director | Buy | C | 0.06 | 564,726 | 35,295 | 12,679,436 | 12.1 M to 12.7 M (+4.66 %) |
| Apr 03 2018 | BNKL | Bionik Laboratorie ... | AUBERTON-HERVE ANDRE-JACQUES | Director | Buy | C | 0.06 | 12,114,710 | 757,169 | 12,679,436 | 564.7 K to 12.7 M (+2,145.24 %) |
| Apr 03 2018 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Option Exercise | A | 0.06 | 5,858,343 | 366,146 | 5,858,343 | |
| Apr 03 2018 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Option Exercise | A | 0.06 | 1,600,640 | 100,040 | 3,361,344 | |
| Apr 03 2018 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Option Exercise | A | 0.06 | 1,760,704 | 110,044 | 3,361,344 | |
| Apr 03 2018 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Buy | C | 0.06 | 12,266,240 | 766,640 | 75,463,389 | 63.2 M to 75.5 M (+19.41 %) |
| Apr 03 2018 | BNKL | Bionik Laboratorie ... | Gaston-Dreyfus Remi | Director | Buy | C | 0.06 | 63,197,149 | 3,949,822 | 75,463,389 | 12.3 M to 75.5 M (+515.21 %) |
| Jan 26 2018 | BNKL | Bionik Laboratorie ... | Dusseux Eric Michel | Chief Executive Off ... | Option Exercise | A | 0.16 | 500,000 | 77,500 | 500,000 | |
| Jan 26 2018 | BNKL | Bionik Laboratorie ... | PRYWATA MICHAL | Chief Technology Of ... | Option Exercise | A | 0.16 | 500,000 | 77,500 | 500,000 | |
| Jan 26 2018 | BNKL | Bionik Laboratorie ... | MARKOW LESLIE NADENE | Chief Financial Off ... | Option Exercise | A | 0.16 | 300,000 | 46,500 | 300,000 | |
| Jan 26 2018 | BNKL | Bionik Laboratorie ... | McCarthy Timothy A. | See Remarks | Option Exercise | A | 0.16 | 100,000 | 15,500 | 100,000 | |
| Sep 15 2017 | BNKL | Bionik Laboratorie ... | Dusseux Eric Michel | Chief Executive Off ... | Option Exercise | A | 0.16 | 6,107,677 | 983,336 | 6,107,677 | |
| Aug 24 2017 | BNKL | Bionik Laboratorie ... | McCarthy Timothy A. | Chief Commercializa ... | Option Exercise | A | 0.21 | 250,000 | 52,500 | 250,000 | |
| Aug 24 2017 | BNKL | Bionik Laboratorie ... | McCarthy Timothy A. | Chief Commercializa ... | Option Exercise | A | 0.21 | 250,000 | 52,500 | 250,000 | |
| Aug 24 2017 | BNKL | Bionik Laboratorie ... | McCarthy Timothy A. | Chief Commercializa ... | Option Exercise | A | 0.21 | 1,500,000 | 315,000 | 1,500,000 | |
| Dec 16 2015 | BNKL | Bionik Laboratorie ... | PRYWATA MICHAL | Chief Operating Off ... | Option Exercise | A | 1.00 | 400,000 | 400,000 | 400,000 | |
| Dec 16 2015 | BNKL | Bionik Laboratorie ... | MATHIEU MARC | Director | Option Exercise | A | 1.00 | 200,000 | 200,000 | 200,000 | |
| Dec 16 2015 | BNKL | Bionik Laboratorie ... | Hariri Robert J | Director | Option Exercise | A | 1.00 | 200,000 | 200,000 | 200,000 | |
| Dec 16 2015 | BNKL | Bionik Laboratorie ... | Bloch Peter D. | Chairman and CEO | Option Exercise | A | 1.00 | 1,000,000 | 1,000,000 | 1,000,000 | |
| Dec 01 2015 | BNKL | Bionik Laboratorie ... | MARKOW LESLIE NADENE | Chief Financial Off ... | Option Exercise | A | 1.22 | 400,000 | 488,000 | 400,000 | |
| Jun 30 2015 | BNKL | Bionik Laboratorie ... | ARCHAMBAUD OLIVIER RENE PIERRE | 10% Owner | Option Exercise | S | 0.00 | 629,138 | 0 | 7,210,768 | |
| Jun 30 2015 | BNKL | Bionik Laboratorie ... | Bloch Peter D. | Chief Executive Off ... | Option Exercise | S | 0.00 | 207,616 | 0 | 6,083,904 | |
| Jun 30 2015 | BNKL | Bionik Laboratorie ... | PRYWATA MICHAL | Chief Operating Off ... | Option Exercise | S | 0.00 | 210,761 | 0 | 7,496,351 | |
| Jun 30 2015 | BNKL | Bionik Laboratorie ... | CAIRES THIAGO MORAIS ULHOA | Chief Technology Of ... | Option Exercise | S | 0.00 | 210,761 | 0 | 7,496,351 | |
| Mar 02 2015 | BNKL | Bionik Laboratorie ... | Kibler Austin | Senior Vice Preside ... | Sell | D | 0.00 | 90,207,241 | 0 | 50,000 | 90.3 M to 50 K (-99.94 %) |
Page: 1